Leucine-rich alpha-2 glycoprotein (LRG), a 50 kDa glycoprotein that contains repetitive sequences with a leucine-rich motif, was originally identified as an inflammatory biomarker for immune-mediated diseases, such as rheumatoid arthritis and IBD [7]. Here, LRG1 is linked to rheumatoid arthritis.